Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venture Life ( (GB:VLG) ) just unveiled an announcement.
Venture Life Group plc, a UK-based consumer healthcare specialist, develops and commercialises self-care products that are typically pharmacist-recommended and distributed through retail and online channels across the UK, Ireland, the U.S. and international markets via distribution partners. Its brands target women’s health, ENT care, glucose management and hormonal health, positioning the Group in the growing global self-care segment.
Venture Life has repurchased 73,862 ordinary shares at a volume-weighted average price of 68.55 pence under its ongoing share buyback programme, and will hold these shares in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 5,739,586 are in treasury, leaving 123,120,559 voting rights outstanding, information that will guide shareholders’ regulatory disclosure calculations and marginally enhances earnings per share potential.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group plc is a UK-headquartered international consumer self-care company focused on proactive healthy longevity within the global consumer healthcare sector. Its portfolio spans women’s intimate health brand Balance Activ, ENT care product Earol, Lift and Glucogel for energy and glucose management, and Health & Her products for the hormonal lifecycle, sold via pharmacies, health and beauty chains, grocery multiples and e-commerce worldwide.
Average Trading Volume: 333,862
Technical Sentiment Signal: Buy
Current Market Cap: £84.41M
Find detailed analytics on VLG stock on TipRanks’ Stock Analysis page.